Literature DB >> 23707489

Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.

Reinoud E Knops1, Louise R A Olde Nordkamp, Joris R de Groot, Arthur A M Wilde.   

Abstract

BACKGROUND: Three incisions in the chest are necessary for implantation of the entirely subcutaneous implantable cardioverter-defibrillator (S-ICD). The superior parasternal incision is a possible risk for infection and a potential source of discomfort. A less invasive alternative technique of implanting the S-ICD electrode--the two-incision technique--avoids the superior parasternal incision.
OBJECTIVE: The purpose of this prospective cohort study was to evaluate the safety and efficacy of the two-incision technique for implantation of the S-ICD.
METHODS: Consecutive patients who received an S-ICD between October 2010 and December 2011 were implanted using the two-incision technique, which positions the parasternal part of the S-ICD electrode using a standard 11Fr peel-away sheath. All patients were routinely evaluated for at least 1 year for complications and device interrogation at the outpatient clinic.
RESULTS: Thirty-nine patients (46% male, mean age 44 ± 15 years) were implanted with a S-ICD using the two-incision technique. During mean follow-up of 18 months (range 14-27 months) no dislocations were observed, and there was no need for repositioning of either the ICD or the electrode. No serious infections occurred during follow-up except for 2 superficial wound infections of the pocket incision site. Device function was normal in all patients, and no inappropriate sensing occurred related to the implantation technique.
CONCLUSION: The two-incision technique is a safe and efficacious alternative for S-ICD implantations and may help to reduce complications. The two-incision technique offers physicians a less invasive and simplified implantation procedure of the S-ICD.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DFT; EIT; ICD; Implantable cardioverter-defibrillator; Implantation technique; S-ICD; Subcutaneous implantable cardioverter-defibrillator; VF; defibrillation threshold; electrode insertion tool; implantable cardioverter-defibrillator; subcutaneous implantable cardioverter-defibrillator; ventricular fibrillation

Mesh:

Year:  2013        PMID: 23707489     DOI: 10.1016/j.hrthm.2013.05.016

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  34 in total

1.  Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique.

Authors:  Elif Kaya; Rolf Alexander Jánosi; Obayda Azizy; Reza Wakili; Tienush Rassaf
Journal:  J Interv Card Electrophysiol       Date:  2018-09-14       Impact factor: 1.900

Review 2.  The subcutaneous ICD-current evidence and challenges.

Authors:  Kiran Haresh Kumar Patel; Pier D Lambiase
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

3.  Substernal lead implantation: a novel option to manage DFT failure in S-ICD patients.

Authors:  M Guenther; S Kolschmann; M Knaut
Journal:  Clin Res Cardiol       Date:  2014-10-02       Impact factor: 5.460

Review 4.  Leadless Cardiac Devices-Pacemakers and Implantable Cardioverter-Defibrillators.

Authors:  Hans Rutzen-Lopez; Jose Silva; Robert H Helm
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

Review 5.  [Journey of the S‑ICD to first-line therapy].

Authors:  Elif Kaya; Reza Wakili; Tienush Rassaf
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-14

6.  Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation.

Authors:  Michaël Peyrol; Jérémie Barraud; Jennifer Cautela; Baptiste Maille; Marc Laine; Laurent Bonello; Franck Thuny; Franck Paganelli; Frédéric Franceschi; Linda Koutbi; Samuel Levy
Journal:  J Interv Card Electrophysiol       Date:  2017-05-23       Impact factor: 1.900

7.  The Emerging Roles of Leadless Devices.

Authors:  Jeffrey Arkles; Joshua Cooper
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

Review 8.  [The subcutaneous cardioverter-defibrillator: When less is more].

Authors:  J Kuschyk; B Rudic; I Akin; M Borggrefe; S Röger
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06-10

9.  Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.

Authors:  Babak Nazer; Zack Dale; Gianmarco Carrassa; Nosheen Reza; Tuna Ustunkaya; Nikolaos Papoutsidakis; Andrew Gray; Stacey J Howell; Miriam R Elman; Paolo Pieragnoli; Giuseppe Ricciardi; Daniel Jacoby; David S Frankel; Anjali Owens; Iacopo Olivotto; Stephen B Heitner
Journal:  Heart Rhythm       Date:  2020-02-18       Impact factor: 6.343

10.  A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter-defibrillator.

Authors:  Yuji Ishida; Shingo Sasaki; Yuichi Toyama; Kimitaka Nishizaki; Yoshihiro Shoji; Takahiko Kinjo; Taihei Itoh; Daisuke Horiuchi; Masaomi Kimura; Michael R Gold; Hirofumi Tomita
Journal:  Heart Rhythm O2       Date:  2020-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.